chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Previously well, received 2nd Anthrax vaccination in Right posterior upper arm on Monday, 7 Jul, 1000, and began to have symptoms 1700 on 8 Jul.  Symptoms included severe headache, neck stiffness, night sweats, right arm pain (from injection site to tips of fingers in right arm), myalgias, malaise, nausea, vomiting, and trouble sleeping.  Some improvement with tylenol, motrin, and zofran which she had at home.  She had a similar but much milder reaction after the first vaccination 2 weeks previously, which resolved after one week.  Taking Anthrax vaccination due to upcoming deployment, no h/o adverse reactions to other vaccinations.  However, she did report sensitivities to other medications (droperidol, narcotics), adhesive sprays (mastisol), home products (soaps, perfumes, creams).  Exam revealed normal vital signs (afebrile), well appearing female, with edematous right arm (circumference increased versus left arm at mid upper arm), slightly erythematous around injection site, otherwise nonfocal exam.
Pt received quad for the first time. She had tri-strain in the past with no problems. This time, the next day she broke out in full body sweat and joints hurt.
fever; body aches; headaches; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 2-year-old female patient received BNT162b2 (BNT162B2), on 25Aug2022 as dose 1, single (Batch/Lot number: unknown) at the age of 2 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Aug2022, outcome "recovered" (29Aug2022), described as "body aches"; HEADACHE (non-serious) with onset Aug2022, outcome "recovered" (29Aug2022), described as "headaches"; OROPHARYNGEAL PAIN (non-serious) with onset Aug2022, outcome "recovered" (29Aug2022), described as "sore throat"; PYREXIA (non-serious) with onset 25Aug2022, outcome "recovered" (29Aug2022), described as "fever".   Additional information: She had a fever that night (25Aug2022) which continued for 3+ days. She also had body aches, headaches, and sore throat. It progressively worsened, Saturday (27Aug2022) being the worst day. It started improving on Sunday (28Aug2022) and symptoms were resolved on Monday (29Aug2022). She was taken to urgent care on Sunday (28Aug2022) and was tested for COVID, flu, and strep, all of which were negative. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
soreness/ Pain; redness; tenderness; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness/ Pain), ERYTHEMA (redness) and TENDERNESS (tenderness) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness/ Pain), ERYTHEMA (redness) and TENDERNESS (tenderness). At the time of the report, PAIN (soreness/ Pain), ERYTHEMA (redness) and TENDERNESS (tenderness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  No treatment information was provided.
pt recv vax 6SEP96 in rt leg & w/in 24hr of vax pt devel diffuse rash all over whole body;the sx resolved in 48hr;pt mom refused the 3rd dose;
This spontaneous report was received from a female patient of unknown age reporting on herself. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with M-M-R II or M-M-VAX for prophylaxis (dose, route of administration, injection site, lot # and expiration date were not reported). It was unknown which vaccine the patient received. On an unknown date in 2015, also reported as 4 years ago, the patient was diagnosed with endometrial cancer (also reported as unspecified cancer diagnosis). It was reported, that the patient was not diagnosed with microsatellite instability-high. On an unknown date, the patient underwent an unspecified surgery for endometrial cancer. On an unknown date, the patient had an unspecified chemotherapy and unspecified radiation therapy for endometrial cancer. It was reported, that the patient could no longer have either in those areas. On an unspecified date in March 2018, reported as last spring, 3 tumor popped up, one in the vaginal area and two in the abdomen, at the port site of the original surgery. On an unspecified date in May 2018, reported as "the patient had been on therapy for a year", the patient started therapy with KEYTRUDA for endometrial cancer, one tumor in the vaginal area and two in the abdomen (formulation, strength, dose, frequency, route of administration, lot # and expiration date were not reported). Additionally, the patient received cannabis sativa oil. It was reported, that the therapy with KEYTRUDA was working well for the patient. It was noted reported that the patient was not eligible for the Support program. The outcome of the events was not provided. The relatedness between the events and the suspect products was not provided. Upon internal review, the events of endometrial cancer, vaginal cancer and abdominal wall neoplasm malignant were considered to be medically significant. Sender's Comments: US-009507513-1905USA012646.
Pt felt dizzy/shaky after receiving vaccine and sat down. She fainted approximately 3 minutes after receiving vaccine. She was unconscious for 1-2 minutes. Ammonia inhalant was used to regain consciousness. Paramedics arrived within 10 minutes. While waiting for paramedics, I used ammonia inhalant 2-3 times because she looked as if she might faint again. She had the urge to vomit, but did not vomit. When paramedics arrived her pulse was fine, and pt was alert. Her blood pressure was low but that is normal for the pt. Her blood sugar reading was 102. Pt was fine at 8:00 that night when I called to check on her and again she was fine on Saturday, November 1.
Pt received VARIVAX instead of ZOSTAVAX. She experienced headache, dizziness, nauseated, faint feeling.
everything smelt rotten and had a rotten, burnt chemical smell / s nasty, horrible horrible smell / symptoms have come back stronger; feels sluggish; Nasty horrible horrible smell and taste which overwheles everything I eat; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (everything smelt rotten and had a rotten, burnt chemical smell / s nasty, horrible horrible smell / symptoms have come back stronger), TASTE DISORDER (Nasty horrible horrible smell and taste which overwheles everything I eat) and SLUGGISHNESS (feels sluggish) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 001B21A) for COVID-19 vaccination.     The patient's past medical history included Sinus infection (Patient went to his physician who diagnosed him with sinus infection and prescribed antibiotics for 10 days and he felt better).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced TASTE DISORDER (Nasty horrible horrible smell and taste which overwheles everything I eat). On 16-Apr-2021, the patient experienced PAROSMIA (everything smelt rotten and had a rotten, burnt chemical smell / s nasty, horrible horrible smell / symptoms have come back stronger) and SLUGGISHNESS (feels sluggish). At the time of the report, PAROSMIA (everything smelt rotten and had a rotten, burnt chemical smell / s nasty, horrible horrible smell / symptoms have come back stronger), TASTE DISORDER (Nasty horrible horrible smell and taste which overwheles everything I eat) and SLUGGISHNESS (feels sluggish) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
I was given the Influenza vaccine in my left arm and the Pneumococcal vaccine in my right arm.  Reaction occured to the Pneumococcal vaccine. Redness and swelling at the injection site.  Hard lump/welt developed after a couple hours at injection site.  Area was swollen and hot, and painful to the touch.  Red area increased in size over the next few days.  The day of the injection I felt like I was running a fever (chills).  Flu like symptoms (fatigue, muscle aches).  Had headache on and off all week.  Injection was given on Monday, symptoms starting to improve the following Friday (current date).  Redness has improved.  Still can feel a lump and it is tender to touch.  Still warm to the touch.  Still have a headache.
Patient due for MCV4, patient inadvertently administered MenB.  Patient called no answer, left a voicemail.
expired dose of Kinrix was administered to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number H99J7, expiry date 26-MAY-2023) for prophylaxis.   On 30-MAY-2023, the patient received Kinrix. On 30-MAY-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: expired dose of Kinrix was administered to a patient). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 31-MAY-2023 The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up via postal. The reporter stated that an expired dose of Kinrix was administered to a patient, which led to expired vaccine used.
i have the same symptoms as if i have covid. every 2 weeks it seems, chills, fever, soreness, body aches, funny taste in mu mouth and so on.  i keep taking tylenol, and flu meds and it goes away for a bit but it comes right back, been tested a few times and nothing.  i am dick of this feeling how do i make it go away.
INAPPROPRIATE DOSE ADMINISTERED; EXPIRED VACCINE ADMINISTERED; SWOLLEN LYMPH NODES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, expiry: 21-SEP-2021) 1 ml, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced inappropriate dose administered, expired vaccine administered, and swollen lymph nodes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swollen lymph nodes, inappropriate dose administered and expired vaccine administered was not reported. This report was non-serious.
Extreme fatigue, extreme headache, extreme bodyaches, burning sensations around entire body, high fever, loss of appetite, waves of light nausea
COVID19 Vaccination EUA - unknown which vaccine. Patient did not have vaccination card with him. States that he got his COVID vaccines through the VA. Unsure of manufacturer. Unable to import any vaccination records. Patient states that he has completed the series and has received 2 Covid Vaccines.  Patient hospitalized acute inpatient due to acute kidney injury with weakness, dizziness, and unsteady gait.
Info has been received from a health professional concerning a 10 year old white male, with no medical history and no allergies, who on 5/31/96 was vaccinated with a dose of varicella virus vaccine live. There was no illness at the time of vaccination and no adverse events following prior vaccination. On 4/13/05 (also reported as 4/13/99) the pt experienced chickenpox breakthrough, during a middle school outbreak, described as a rash, moderate, generalized, mild, with a few scattered lesions, feeling of fatigue and weak, and a fever of 100.4 for 4 days. It was reported that the pt recovered without hospitalization. Unspecified medical attention was sought. No product quality complaint was involved. No further info was provided. Additional info is not expected.
starting less than 48 hours post vaccine i started having severe lower abdominal pains and cramping which have now continued for the following seven (7) weeks.  There have been a few periods of improvement but then the pains return as bad as initially. Also bloody stool on several occasions. I did NOT have these pains prior to vaccine. Pains are 7-8 on 10 point scale. CT scan shows inflammation at ileum which was not present on prior CTs.  Given Lactinex and Hyoscyamine for symptoms but pain has not resolved. I have had to postpone 2nd dose indefinitely since doctors cannot r/o that vaccine is cause. I am  very concerned to learn if other patients with ileostomies have suffered similar reactions.
Pt recv vax on 10/13/97; subsequently pt exp 2 in area of redness at vax site & lump under site.
Discharge Summary states SIDS. Autopsy Report received on 2/16/2005 confirms SIDS.
Case number PHEH2014US025078, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 50-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 13 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursions began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Pt had a positive pre-operative screening COVID test. Asymptomatic at time of testing
pt devel T105 on APAP every 4hr;sx dx febrile sz;
Headache  chills, feels hot (no fever), body aches, stuffiness, and headache
3in x 3in hive with erythema and multiple small pin pointed vesicles and induration, swelling to (L) upper arm where the immunization was given 2 days ago. Pt. denies fever, denies SOB, denies, N, V, D. C/o some tenderness. Plan: hydroxyzine 10/5 for itching, TYLENOL for pain.
5 minutes after she got the shot she started sweating, feeling hot around her neck. Her mom told us she had POTS. We got her a bottle water , she started drinking it and then said she felt dizzy. She wanted something salty so we got her some plain chips. once she ate that she started feeling better. We had her remain seated for 30 min. After that, she stood up and said she was no longer dizzy or hot feeling.
No adverse event; got 0.25 ml instead of the full 0.5 ml; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (got 0.25 ml instead of the full 0.5 ml) and NO ADVERSE EVENT (No adverse event) in a 15-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 03-Nov-2022, the patient experienced ACCIDENTAL UNDERDOSE (got 0.25 ml instead of the full 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (got 0.25 ml instead of the full 0.5 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (got 0.25 ml instead of the full 0.5 ml).    Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
After "2shots of the vaccine", his "PSA reading went down". "Before, he had high reading of PSA but the numbers dropped significantly from last year; This is a spontaneous report received from Pfizer sponsored program. A contactable male consumer (patient) reported for himself. A 74-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection) via an unspecified route of administration on 23Feb2021 (at the age of 74-year-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 via an unspecified route of administration, on 02Feb2021 (at the age of 74-year-old) (Batch/Lot Number: not reported) for COVID-19 immunization as no reaction on previous exposure to vaccine. Patient reported after the second dose he had tested for PSA, so his PSA is reading after the second shot went down so before he was having high reading of the PSA but although it is better if the numbers are low, he had drop significant live from last year. Consumer stated all right, I just want to point out it not a problem am just finding me out more information whether vaccine does affect the Prostate reading. Query response received and confirmed the patient first name. The clinical outcome of event was unknown.
7-29-15 received PREVNAR. 8-5-15 swelling and itching at site. Some swelling down arm into (L) index finger. 8-12-15 swelling resolved + (L) finger resolved swelling.
Right arm pain since 11-11-04, had fever in arm until 11-20-04. No neuropathy. Treated with heat to arm after fever subsided and ibuprofen.
He reported getting covid in Apr2022; He reported getting covid in Apr2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 47-year-old male patient received BNT162b2 (BNT162B2), on 23Feb2021 as dose 1, single (Lot number: EN6198), in left arm, on 16Mar2021 as dose 2, single (Lot number: EN6208), in left arm and on 09Oct2021 as dose 3 (booster), single (Lot number: FF8839) at the age of 47 years, in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. There were no other vaccines received within four weeks. The patient did not have COVID prior to vaccination. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Apr2022, outcome "recovered" and all described as "He reported getting covid in Apr2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2022) Positive, notes: Nasal swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.
Case number PHEH2014US022730, is an initial spontaneous report from a health care professional (office manager) received on 11 Nov 2014. This report refers to a 17-year-old male patient. Past medical history and concomitant medications were not reported. The patient received only Men CWY liquid conjugate component of MENVEO, batch number: X14055) without being reconstituted with Men A lyophilized conjugated component intramuscularly on 07 Nov 2014. No adverse reaction reported following this medication error (inappropriate preparation of medication).
pt recv vax & JAN97 pt exp waking up in the morning w/bruises all over him & there was blood on pillows;pt seen by MD whol felt pt had ITP & pt was hosp for 3 days;tx w/med;
The symptoms were: feeling of illness, exhaustion, nausea, aches and pains (specially in joint areas of legs, hips, arms), head aches. After 5 days, the head aches became more severe and experienced every day.  Nine weeks out, the head aches are still very painful but are only 4-5 days a week.  Ten weeks out the muscle pain comes and goes.  Some days I am almost unable to walk due to muscle pain.  The muscle pain has spread to other parts of the body compared to the first week.  I am now experiencing severe pain in the right hand (almost to the point that typing is extremely difficult).  Pain still exist in the right leg and hip area.  It now radiates down to the foot.  Both upper arms will experience sharp pain, usually at night when resting.
Headache, Myalgia, Arthralgia, Fever & Diarrhea Narrative:
2/3- aching. Fever 100.2. Nausea. Headache. Excerdrine taken 4 x that day and relieved the symptoms.   2/5- red hard itchy bumpy raised rash below injection site. Size is 9.2cm x10.6cm.  Swollen lymph node.
Patient felt syncope / fainting unknown cause . Onsite EMS was called vitals BP 100/54  100% O2 room air HR 88  BG 130  Patient refused evaluation/care went home against medical advice.
Headache, body aches (specifically to back), fatigue; Headache, body aches (specifically to back), fatigue; Headache, body aches (specifically to back), fatigue; This is a spontaneous report from non-contactable consumer, the patient.  A 26-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730), via an unspecified route of administration on 17Dec2020 at 20:00 (at the age of 26-years-old) in the right arm as a single dose for COVID-19 immunization.   The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included omeprazole (PRILOSEC) and fexofenadine hcl (ALLEGRA); both for unknown indications from unknown dates and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient previously took azithromycin (ZITHROMAX) from an unknown date to an unknown date for an unknown indication and experienced drug allergy.  On 18Dec2020 at 04:00, the patient experienced headache, body aches (specifically to back), and fatigue; all reported as non-serious. The patient did not receive any treatment for the events. The clinical outcomes of headache, body aches (specifically to back), and fatigue were recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
localized redness, swelling @ site of DTP/HIB inj @ 12:00 today;began crying @ 2:30 still crying @ 4PM; can be distracted @ times goes 10min w/o crying;-smiling during this time;
This spontaneous report as received from a pharmacist refers to a 73 years old female patient with no drug allergy and no pertinent medical history. The patient was vaccinated with! vial of ZOSTAVAX (lot# reported as H017448,Exp 20-DEC-2012) subcutaneous on 30-NOV-2012. No other co-suspects were reported. Concomitant medications included DIOVAN, vitamins (unspecified) and fish oil. On approximately 14-DEC-2012, 2 weeks after the vaccination, the reporter stated that patient developed redness at the injection site after receiving a dose of ZOSTAVAX. The site was red but now it was getting better. The color of the injection site is now more "purple" than red. There was no treatment information and no lab information for the event. The patient had sought medical attention via saw the pharmacist. The outcome was reported as recovering. Additional information has been requested.